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The Effect of Flavored E-cigarettes 
on Murine Allergic Airways Disease
David G. Chapman  1,3,4, Dylan T. Casey2, Jennifer L. Ather1, Minara Aliyeva1, 
Nirav Daphtary1, Karolyn G. Lahue2, Jos L. van der Velden2, Yvonne M. W. Janssen-Heininger2 
& Charles G. Irvin1
Flavored e-cigarettes are preferred by the majority of users yet their potential toxicity is unknown. 
Therefore our aim was to determine the effect of selected flavored e-cigarettes, with or without 
nicotine, on allergic airways disease in mice. Balb/c mice were challenged with PBS or house dust 
mite (HDM) (Days 0, 7, 14–18) and exposed to room air or e-cigarette aerosol for 30 min twice daily, 
6 days/week from Days 0–18 (n = 8–12/group). Mice were exposed to Room Air, vehicle control 
(50%VG/%50PG), Black Licorice, Kola, Banana Pudding or Cinnacide without or with 12 mg/mL 
nicotine. Mice were assessed at 72 hours after the final HDM challenge. Compared to mice challenged 
with HDM and exposed to Room Air, nicotine-free Cinnacide reduced airway inflammation (p = 0.045) 
and increased peripheral airway hyperresponsiveness (p = 0.02), nicotine-free Banana Pudding 
increased soluble lung collagen (p = 0.049), with a trend towards increased airway inflammation with 
nicotine-free Black Licorice exposure (p = 0.089). In contrast, all e-cigarettes containing nicotine 
suppressed airway inflammation (p < 0.001 for all) but did not alter airway hyperresponsiveness or 
airway remodeling. Flavored e-cigarettes without nicotine had significant but heterogeneous effects 
on features of allergic airways disease. This suggests that some flavored e-cigarettes may alter asthma 
pathophysiology even when used without nicotine.
Electronic cigarette (e-cigarette) use has dramatically increased in recent years due to its portrayal as a healthier 
alternative to tobacco cigarettes. E-cigarette use amongst high school aged children in the US jumped from 1.5% 
in 2011 to over 15% in 20151. Similarly, almost 9% of 18–24 year olds are current e-cigarette users2. E-cigarettes 
administer nicotine as an aerosol, do not require tobacco combustion and therefore are assumed to remove the 
risks associated with tobacco cigarettes. However, e-cigarettes contain numerous toxic compounds long associ-
ated with adverse respiratory outcomes3. The humectant propylene glycol leads to respiratory symptoms when 
inhaled4, while nicotine adversely effects respiratory health5. E-cigarette liquids are also available in a seemingly 
limitless combination of flavor additives, with almost all users under 30 and almost 70% of older adults using fla-
vored e-cigarettes6. Additionally, up to 66% of US high school aged children use e-cigarettes with only flavoring/s 
i.e. no nicotine7. However, e-cigarette flavorings have been shown to have toxic effects on human airway epithelial 
and immune cells8–11. Despite the high use of flavored e-cigarettes and the potential toxicity, little is known as to 
the adverse effects of flavored e-cigarettes on lung function and respiratory health.
Asthmatics are particularly susceptible to the effects of toxic, inhaled substances such as tobacco, with tobacco 
smoking asthmatics reporting worse asthma control, more unscheduled health care visits, and a greater require-
ment for oral corticosteroids12. This increased disease severity is due to both worse lung function13 and greater 
severity of airway hyperresponsiveness14. There is currently little evidence as to the effect of e-cigarette use in 
patients with asthma. One study reported that asthmatic patients who transitioned from tobacco cigarette smok-
ing to e-cigarette use reported improved asthma symptoms and lung function15. However, this does not address 
whether e-cigarettes themselves may be detrimental to asthmatics. In healthy volunteers, acute e-cigarette use can 
reduce lung function16–18. Importantly, the reduction in lung function was exaggerated in patients with asthma18, 
suggesting that asthmatics may be more susceptible to the effects of e-cigarettes. However, it is unknown whether 
these acute effects of e-cigarettes on lung function reflect the potential effects on asthma pathophysiology.
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Since e-cigarettes contain numerous toxic compounds and reduce lung function following acute use, our 
objective was to determine the effect of flavored e-cigarettes on the development and severity of allergic airways 
disease (Fig. 1). To determine whether any effects were due to nicotine, we compared the effect of different fla-
vored e-cigarettes with nicotine and without nicotine. A nicotine concentration of 12 mg/mL was chosen based 
upon reported use patterns amongst daily e-cigarette users when the study was developed19,20. E-cigarette flavors 
were chosen based on the in vitro toxicity of cinnamon flavors21 (Kola and Cinnacide) and creamy/buttery fla-
vors8,9 (Banana Pudding). Black Licorice was chosen as a flavor distinct from the aforementioned flavors.
Results
Effect of e-cigarette exposure on weight. The effect of e-cigarette exposure on weight gain was assessed 
by measuring weight on Day 21 before the assessment of lung function (Supplementary Fig. 1). As sex is a deter-
minant of body weight, data from female and male mice were analyzed separately. There was no effect of HDM on 
weight in female or male mice exposed to e-cigarette with or without nicotine (p ≥ 0.2 for all). When combining 
both PBS and HDM groups, there was no difference in weight between female mice exposed to Room Air and 
any of the e-cigarettes. In contrast, male mice exposed to PG/VG, Black Licorice and Cinnacide with nicotine 
had reduced weight compared to Room Air exposed mice (p < 0.05 for all). Similarly, there was a trend towards 
reduced weight in mice exposed nicotine-free Kola compared to Room Air (p = 0.065).
Effect of e-cigarette exposure on HDM-induced airway inflammation. Flavored e-cigarettes without 
nicotine. To determine the effect of nicotine-free e-cigarette exposure on allergic airways inflammation following 
HDM we measured inflammatory cells in BALF (Fig. 2, left hand panels). Total leukocytes, eosinophils, neutrophils 
and macrophages in BALF were all increased with HDM (p < 0.0001 for all). However, total leukocytes and eosin-
ophils were reduced in HDM mice exposed to Cinnacide without nicotine compared to Room Air (p = 0.045 and 
0.02, respectively). In contrast, macrophages were increased in HDM mice exposed Black Licorice compared to 
Room Air (p = 0.05), with a trend towards increased total leukocytes (p = 0.089). PG/VG, Kola or Banana Pudding 
did not alter total leukocytes, eosinophils or macrophrages. Similarly, there was no difference in neutrophils between 
HDM mice exposed to Room Air and those exposed to any of the nicotine-free e-cigarettes. This suggests that 
flavored e-cigarettes without nicotine have variable effects on airway inflammation during allergic airways disease, 
with the direction of the effect and the type of inflammatory cells affected dependent upon the specific flavor.
Flavored e-cigarettes with nicotine. As shown in Fig. 2 (right hand panels), all e-cigarettes containing 12 mg/mL 
nicotine dampened airway inflammation. Compared to HDM mice exposed to Room Air, mice exposed to PG/
VG and all flavored e-cigarettes had reduced total leukocytes (p < 0.001 for all), eosinophils (p < 0.001 for all) 
and macrophages (p < 0.05 for all). In contrast, while there was no difference between HDM mice exposed to 
Room Air and any of the flavored e-cigarettes (p > 0.5 for all), there was an increase in neutrophils in HDM mice 
exposed to PG/VG compared to Room Air (p < 0.001).
Importantly, the allergic airways disease in the present model was predominantly eosinophilic and the per-
centage of eosinophils was largely unaltered by e-cigarette exposure (Supplementary Fig. 2). However, there was 
a small skewing towards a reduced proportion of eosinophils in HDM mice exposed to VG/PG with nicotine 
and Black Licorice with nicotine compared to Room Air HDM (p < 0.01 and 0.045, respectively). Representative 
H&E stained images of the extent of inflammatory cells surrounding the airway is shown in Supplementary 
Fig. 3. Taken together, the present findings suggest that the effect of flavored e-cigarettes without nicotine on 
HDM-induced airway inflammation is dependent upon the specific flavor. In contrast, nicotine universally sup-
pressed airway inflammation regardless of the flavor.
Effect of e-cigarettes on baseline lung function. Lung function was measured at baseline before the 
methacholine challenge. In mice exposed to e-cigarettes without nicotine, HDM treatment increased baseline Rrs, 
Rn, G and H (p < 0.05 for all) but did not alter Ers (p = 0.25). However, there was no difference in any measure of 
airway mechanics between HDM treated mice exposed to Room Air and any of the e-cigarette exposures (p > 0.5 
for all post-hoc comparisons). Similarly, in mice exposed to e-cigarettes with 12 mg/mL nicotine, HDM treatment 
increased AHR as measured by Rrs, Rn, G and H (p < 0.05 for all) but not by Ers (p = 0.51). Again, none of the 
nicotine e-cigarette exposures had an effect on any measure of baseline airway mechanics (p > 0.4 for all).
Figure 1. Schematic representation of the induction of allergic airways disease with concomitant exposure 
to e-cigarette vapor. Mice were administered intranasal house dust mite (HDM) or phosphate buffered 
saline (PBS) on days 0, 7 and 14–18. Starting on day 0 and continuing through day 18, mice were exposed to 
e-cigarette aerosol for 30 min twice/day, 6 days/week. Mice were evaluated on day 21, 72 hours following the 
final HDM/PBS instillation.
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Figure 2. The effect of electronic cigarettes without and with nicotine on airway inflammation in allergic 
airways disease. Airway inflammation measured in bronchoalveolar lavage fluid from mice challenged with 
phosphate buffered saline (control) or house dust mite (HDM) and exposed to Room Air (RA, blue), 50% 
propylene glycol/50 %vegetable glycerin (PG/VG, vehicle, green), Black Licorice (BL, black), Kola (dark red), 
Banana Pudding (BP, yellow) or Cinnacide (Cin, red). Mice were exposed to e-cigarette liquid without nicotine 
(left hand panels, 0 mg/mL) or e-cigarette liquid containing 12 mg/mL nicotine (right hand panels). Shown are 
(A) total leukocyte cell counts, (B) eosinophils, (C) neutrophils and (D) macrophages. Data are presented as 
mean ± SEM of 6–12 mice/group. In mice exposed to nicotine-free e-cigarette, HDM increased total leukocytes, 
eosinophils, neutrophils and macrophages (HDM effect p < 0.001 for all). In mice exposed to e-cigarette with 
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Effect of e-cigarettes on HDM-induced airway hyperresponsiveness. Flavored e-cigarettes without 
nicotine. The effect of e-cigarettes on AHR was determined by measurement of changes in lung function during 
a methacholine challenge (Fig. 3). In mice exposed to e-cigarettes without nicotine, HDM treatment increased 
AHR as measured by Rrs, Ers, Rn, G and H (p < 0.001 for all). There was no difference between HDM treated 
mice exposed to Room Air and any of the e-cigarette exposures as measured by Rrs (p > 0.8 for all), Ers (p > 0.1 
for all), Rn (p > 0.5 for all) and G (p > 0.15 for all) at the highest dose of methacholine. However, AHR measured 
by H at the highest dose of methacholine was increased in HDM mice exposed to Cinnacide without nicotine 
compared to Room Air HDM (p = 0.02). There was no difference in H at 50 mg/mL methacholine between the 
other e-cigarette exposures and Room Air (p > 0.1 for all).
Flavored e-cigarettes with nicotine. In mice exposed to 12 mg/mL nicotine, HDM treatment increased AHR as 
measured by Rrs, Ers, Rn, G and H (p < 0.001 for all). However, there was no difference between HDM treated 
mice exposed to Room Air and any of the e-cigarette exposures as measured by Rrs (p > 0.8 for all), Ers (p > 0.9 
for all), Rn (p > 0.8 for all), G (p > 0.9 for all) and H (p > 0.5 for all) at the highest dose of methacholine.
Effect of e-cigarette exposure on HDM-induced airway remodeling. We determined the effect of 
e-cigarettes on airway remodeling through measurement of soluble lung collagen content and histological assess-
ment of mucous hyperplasia from PAS stained lung tissue (Fig. 4 and Supplementary Fig. 4). In mice exposed 
to nicotine-free e-cigarettes, HDM treatment increased soluble content (p < 0.0001), with the amount of soluble 
collagen increased in mice exposed to Banana Pudding compared to Room Air exposure (0.049). There was no 
difference between HDM treated mice exposed to Room Air and the other nicotine-free e-cigarettes (p > 0.9 for 
all). In contrast, despite an increase in airway epithelial PAS staining with HDM treatment (p < 0.0001), there 
was no difference between HDM treated mice exposed to Room Air and any of the e-cigarettes without nicotine 
(p > 0.9 for all).
In mice exposed to 12 mg/mL nicotine, soluble lung collagen was increased with HDM treatment (p < 0.0001) 
but there was no difference between mice exposed to Room Air and any of the e-cigarettes (p > 0.9 for all). 
Similarly, HDM treatment increased airway epithelial PAS staining (p < 0.0001) but there was no difference in 
PAS staining between HDM treated mice exposed to Room Air (p > 0.45 for all). Representative PAS stained 
images are shown in Supplementary Fig. 3.
Discussion
This is the first study to determine the effects of flavored e-cigarettes with and without nicotine on allergic airways 
disease. Our findings suggest that flavored e-cigarettes without nicotine can alter allergic airways disease but that 
the effect is dependent upon the specific flavor. Indeed, the effect of nicotine-free e-cigarette exposure varied 
greatly between the flavors: Cinnacide suppressed airway inflammation and increased peripheral AHR, Banana 
Pudding increased soluble collagen content, and there was a trend towards exaggerated airway inflammation in 
mice exposed to Black Licorice. On the other hand, nicotine universally dampened airway inflammation inde-
pendent of flavor with no effect on AHR or airway remodeling. These findings suggest that flavored e-cigarettes 
have the potential to alter the pathophysiology associated with allergic airways disease, but that the direction and 
extent of the effect is dependent upon exposure to a specific flavor.
Our findings highlight the variable effect of flavored e-cigarettes on airway inflammation and that the sup-
pression caused by nicotine is independent of flavor. In the present study Black Licorice exaggerated airway 
inflammation whereas Cinnacide caused suppression. Several studies have reported varied in vitro toxicity of 
flavored e-cigarettes on a variety of respiratory and non-respiratory cell types8–11. Consistent with our findings 
regarding Cinnacide, Clapp et al.9 reported suppressed immune responses in human alveolar macrophages and 
neutrophils exposed to cinnamon flavored e-cigarettes. The authors subsequently replicated these findings using 
the flavor additive cinnamaldehyde leading them to conclude that cinnamaldehyde was detrimental to immune 
cell function. This is consistent with the anti-inflammatory effect of cinnamaldehyde in a mouse model of cardiac 
inflammation22. Although it is likely that Cinnacide used in the present study contained cinnamaldehye, this was 
not confirmed and therefore we can only speculate on its role in the current findings.
In contrast to nicotine-free e-cigarette exposure, there was a ubiquitous suppression of airway inflammation 
with e-cigarette exposure containing nicotine. Nicotine is known to have anti-inflammatory properties23,24 and 
findings with tobacco smoke exposure suggest that reduced airway inflammation is due to abnormal eosinophil 
migration into the airways25. Reduced eosinophilia in mice with allergic airways disease exposure to e-cigarette 
containing nicotine is consistent with reduced eosinophilia in asthmatics who smoke tobacco cigarettes com-
pared to asthmatic non-smokers26. Furthermore, a recent study reported that e-cigarette vapor condensate led 
to alveolar macrophage apoptosis and necrosis, both of which occurred to a greater extent when the exposure 
contained nicotine27. Alveolar macrophages are crucial to innate immunity28 and suppression of macrophage 
immune function by e-cigarettes would be expected to compromise the immune response to infection. In addi-
tion, wide-spread suppression of immune-related gene expression has been reported in nasal epithelial cells from 
e-cigarette users29. The airway epithelium is also crucial in coordinating the innate immune response to infec-
tion30 with abnormal airway epithelial responses correlated with the severity of viral exacerbations in asthma31. 
Indeed, there is growing in vitro and mouse model evidence that e-cigarette use is associated with impaired 
nicotine, HDM increased total leukocytes (p < 0.001), eosinophils (p < 0.001) and neutrophils (p < 0.002) but 
did not alter macrophages (HDM effect p = 0.16). Comparisons between HDM treated mice exposed to Room 
Air HDM and exposed to e-cigarettes were made by Dunnett analyses: *p < 0.05, **p < 0.01 and #p < 0.09.
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anti-bacterial and anti-viral responses32–34. Although exposure to Cinnacide without nicotine suppressed airway 
inflammation in the present study, it is unclear whether this reflects the potential to contribute to an impaired 
response to infection. However, recent findings of reduced airway ciliary function in vitro35 strengthen the spec-
ulation that cinnamon-flavored e-cigarettes may contribute to immune dysfunction.
Figure 3. The effect of electronic cigarettes without and with nicotine on the severity of airway 
hyperresponsiveness in allergic airways disease. Airway hyperresponsiveness to methacholine was measured 
by: (A) respiratory system resistance (Rrs); (B) respiratory system elastance (Ers); (C) Newtonian resistance 
(Rn); (D) tissue damping (G); (E) tissue elastance (H). Mice were challenged with phosphate buffered saline 
(PBS control, dotted line) or HDM (solid line) and exposed to Room Air (RA, blue), 50% propylene glycol/50% 
vegetable glycerin (PG/VG, vehicle, green), Black Licorice (BL, black), Kola (dark red), Banana Pudding (BP, 
yellow) or Cinnacide (Cin, red). Mice were exposed to e-cigarette liquid without nicotine (left hand panels, 
0 mg/mL) or e-cigarette liquid containing 12 mg/mL nicotine (right hand panels). Parameters of airway 
mechanics were measured at baseline (B), after saline control (S) and after each dose of methacholine (3.1, 12.5, 
25 and 50 mg/mL). The response to methacholine at each dose was quantified as the average of the three peak 
measurements for each parameter. Full dose-response curves and the response at 50 mg/mL methacholine are 
shown. Data are presented as mean ± SEM of 6–12 mice/group. In mice exposed to nicotine-free e-cigarette, 
HDM increased Rrs, Ers, Rn, G and H (HDM effect p < 0.001 for all). In mice exposed to e-cigarette with 
nicotine, HDM increased Rrs, Ers, Rn, G and H (HDM effect p < 0.001 for all). Comparisons between HDM 
treated mice exposed to Room Air HDM and exposed to e-cigarettes were made by Dunnett analyses: *p < 0.05.
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There is currently a lack of evidence in both animal models and human data on the effect of e-cigarettes on 
lung function. In the present study, AHR was increased in mice exposed to Cinnacide without nicotine, despite 
having reduced airway inflammation. Cinnamaldehye, the characteristic component of cinnamon flavoring, 
is known to activate transient receptor potential ankyrin 1 (TRPA1) in the upper airways leading to cough36. 
However, this would be expected to increase AHR measured by central airway narrowing (Rn) and not tissue 
elastance, as reported in the present study. The reduction in in vitro ciliary function in response to cinnamon 
flavored e-cigarette exposure37 would be expected to reduce mucus clearance. Mucus production during meth-
acholine challenge is thought to contribute to AHR in allergic airways disease via increased airway closure, as 
measured by tissue elastance (H)38. Therefore, an impairment in mucus clearance would lead to increased airway 
closure during methacholine challenge and increased AHR as measured by H, as seen in the present study follow-
ing exposure to the Cinnacide e-cigarette flavor.
There was no effect of exposure to the vehicle humectant PG/VG or e-cigarettes containing nicotine on AHR. 
However, we utilized a murine model of allergic airways disease that involves relatively short-term exposure to 
e-cigarette aerosol. Two previous studies have measured the effect of long-term e-cigarette exposure on airway 
mechanics and AHR in non-allergic mice. Larcombe39 reported worse baseline mechanics in mice exposed to 
tobacco flavored e-cig with 100% VG or 100% PG for 8 weeks, with and without nicotine. Furthermore, expo-
sure to 100% VG increased AHR, again regardless of the presence of nicotine, while 100% PG had no effect. In 
contrast, Garcia-Arcos40 reported increased AHR following 16 weeks of exposure to nebulized e-cigarette liquid 
containing nicotine (50% PG/VG) but not nicotine-free liquid. Importantly, the two studies differ in respect to 
heating of the liquid, since Garcia-Arcos et al.40 nebulized the liquid whereas Larcombe et al.39 used a commercial 
e-cigarette device. Therefore these findings may reveal that long-term nicotine inhalation promotes AHR whereas 
the development of AHR due to vegetable glycerin requires both long-term exposure and heating of the liquid. 
This is possibly related to the production of toxic aldehydes and/or acrolein caused by heating of vegetable glyc-
erin41 or metal nanoparticles emitted from device itself when heated42.
There is a similar lack of evidence on the effect of e-cigarettes on lung function in humans. Thirty minutes of 
nicotine-free e-cigarette use (70% PG/30% VG) was shown to have no effect on spirometric or forced oscillation 
Figure 4. The effect of electronic cigarettes without and with nicotine airway remodeling in allergic airways 
disease. Mice were challenged with phosphate buffered saline (control) or HDM and exposed to Room Air 
(RA, blue), 50% propylene glycol/50% vegetable glycerin (PG/VG, vehicle, green), Black Licorice (BL, black), 
Kola (dark red), Banana Pudding (BP, yellow) or Cinnacide (Cin, red). Mice were exposed to e-cigarette liquid 
without nicotine (left hand panels, 0 mg/mL) or e-cigarette liquid containing 12 mg/mL nicotine (right hand 
panels). Airway remodeling was measured as (A) soluble collagen (B) the percentage of Periodic Acid-Schiff 
(PAS) staining within the airway epithelial layer. Data are presented as mean ± SEM or Box-and-whisker plots 
of 6–12 mice/group. In mice exposed to nicotine-free e-cigarette, HDM increased soluble collagen and PAS 
staining (HDM effect p < 0.001 for all). In mice exposed to e-cigarette with nicotine, HDM increased soluble 
collagen and PAS staining (HDM effect p < 0.001 for all). Comparisons between HDM treated mice exposed to 
Room Air HDM and exposed to e-cigarettes were made by Dunnett analyses: *p < 0.05.
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technique measurements in healthy or asthmatic non-smokers43. Similarly, Flourish et al.44 found no effect of 
30 minutes of e-cigarettes containing nicotine and tobacco flavor (>60% PG) on spirometry in healthy tobacco 
smokers. In contrast, Ferrari et al.16 reported that five minutes of using nicotine-free e-cigarettes containing hazel-
nut flavor additives reduced PEF and FEV1 in tobacco smokers but not non-smokers. Vardavas et al.17 also reported 
that 5 min e-cigarette use using liquid containing nicotine and tobacco flavor (>60% PG) in healthy tobacco 
smokers increased respiratory system resistance but did not alter reactance. Recently, Lappas et al.18 reported that 
10 puffs of an e-cigarette containing nicotine and tobacco flavor worsened respiratory system resistance and reac-
tance in healthy subjects and mild asthmatics. These effects were exaggerated in the asthmatics but had resolved 
to baseline within 15 min in both groups. Although there are several differences between these human studies, it 
was the three studies of acute use (5 min or 10 puffs) that reported abnormal lung function whereas the longer 
studies did not (30 min). It is therefore attractive to speculate that initial inhalation of e-cigarette aerosol induces 
bronchoconstriction which subsides with continued use. Indeed, one study reported such a time-dependent effect 
of e-cigarette use on cough reflex sensitivity45. However, the contribution of sustained, long-term use on the devel-
opment of abnormal lung function and AHR remains to be elucidated.
Exposure to Banana Pudding without nicotine increased soluble lung collagen content in mice with allergic 
airways disease. In contrast, there was no effect of the other nicotine-free flavored e-cigarettes and all e-cigarette 
exposures containing nicotine. Similarly, a previous study found no effect of e-cigarette aerosol containing 
nicotine on lung fibrosis in non-allergic mice46. This may suggest that airway remodeling is linked to specific 
flavor additives rather than nicotine. For example, diacetyl (2,3-butanedione) is found in numerous common 
flavors such47 as “buttery/creamy” and fruit flavors, and has been detected in many flavored e-cigarette liquids48. 
Diacetyl and related chemicals cause lung fibrosis in rodents49 and led to bronchiolitis obliterans in workers at 
a microwave-popcorn plant50, highlighting the potential for flavored e-cigarettes to contribute to lung fibrosis. 
Additionally, Crotty-Alexander et al.51 reported renal, hepatic and cardiac fibrosis in mice following long-term 
(3/6 months) exposure to non-flavored e-cigarette aerosol containing nicotine suggesting the relationship 
between e-cigarette exposure and fibrosis may differ across different organs.
Although the present study does not directly compare to tobacco exposure, findings from several tobacco 
exposure models allow indirect comparison. In the present study, the effect of e-cigarettes with nicotine was 
confined to suppression of allergic airway inflammation, with no effect on AHR or features of airway remod-
eling. Lancaster et al.52 induced allergic airways disease over 2.5 weeks with tobacco cigarette smoke exposure 
throughout. Cigarette smoke exaggerated allergic airways inflammation, due to effects on eosinophils and neutro-
phils, increased AHR and increased mucous hyperplasia. Using an identical study design, Kumar et al.53 reported 
that tobacco cigarette smoke increased HDM-induced airway eosinophils, neutrophils and mucous metaplasia, 
although effects on AHR did not reach significance. Similarly, concurrent exposure to ovalbumin and tobacco 
cigarette smoke contributes to more severe allergic airways inflammation, due to effects on eosinophils and neu-
trophils, and AHR54. These findings of increased airway inflammation, AHR and features of airway remodeling in 
tobacco models similar to the present study may suggest that e-cigarettes are less likely to worsen asthma patho-
physiology than tobacco cigarette smoking. However, the present study used a mild exposure regime when com-
pared to those used for tobacco exposure. In our study, mice were exposed to e-cigarettes for 30 min twice/day 
whereas Lanckacker et al.52 and Moerloose et al.54 used four exposures/day, and Kumar et al.53 used three expo-
sures/day. Therefore, it is possible that the lack of effect of e-cigarettes with nicotine on AHR and airway remod-
eling in the present study is due to reduced exposure compared to these tobacco mouse models. Nonetheless, a 
potential reduction in harm with e-cigarettes compared to tobacco cigarettes is consistent with the reduction in 
the extent and number of toxic particles in e-cigarette aerosol compared to tobacco smoke55. This speculation of 
reduced harm with e-cigarettes is strengthened by the single report of improved lung function, AHR and symp-
toms in asthmatic tobacco smokers who transition to e-cigarettes15.
The present study evaluated several different flavored e-cigarettes in a well-described animal model of allergic 
disease; however, there are a few limitations that should be mentioned. Firstly, liquids were purchased from dif-
ferent companies who are likely to have different manufacturing practices. The effect of e-cigarettes containing 
nicotine on airway inflammation was the same for all liquids suggesting minimal effects of any differences in 
manufacturing procedures. However, there was a small difference in the percentage of PG and VG between the 
liquids, with control and Black Licorice used at 55%/45% while the other liquids were 50%/50%. The combination 
of flavor aldehydes and PG produces PG acetals, with the amount measured dependent upon PG content i.e. 70% 
PG > 50% PG > 30% PG56. However, it is unknown whether PG acetal formation is greater with 55% PG com-
pared to 50% PG, and whether this could lead to the increased airway inflammation measured in mice exposed 
to Black Licorice. Lastly, while we endeavored to use the same commercial liquid with and without nicotine, we 
were unable to obtain the Atomic Cinnacide flavor without nicotine due to discontinuation by the manufacturer. 
We therefore utilized a similarly strong cinnamon flavor based on consumer reviews (Cinnacide). Given that 
both e-cigarettes liquids dampened airway inflammation, the difference in manufacturer did not appear to have 
a significant effect on the overall findings.
To assess the potential toxicity of flavored e-cigarette to patients with asthma the present study investigated the 
effects of various flavored e-cigarettes with and without nicotine on a mouse model of allergic airways disease. In 
this model of mild exposure, e-cigarettes with and without nicotine had substantially different effects. Depending 
upon the specific flavor, e-cigarettes without nicotine enhanced or suppressed airway inflammation, increased 
airway hyperresponsiveness and increased features of airway remodeling. In contrast, there was a consistent 
suppression of airway inflammation without any effect on AHR or airway remodelling due to e-cigarettes with 
nicotine, regardless of the flavor. These findings highlight the potential for flavored e-cigarettes, in the absence of 
nicotine, to negatively contribute to asthma outcomes and warrant caution in promoting their use to patients with 
asthma. Future investigation into the individual chemical constituents of e-cigarettes driving these toxic effects 
may provide important insight for the regulation of e-cigarettes.
8Scientific RepoRtS |         (2019) 9:13671  | https://doi.org/10.1038/s41598-019-50223-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
Materials and Methods
Study design. All experiments were approved by the Institutional Animal Care and Use Committee at the 
University of Vermont (#15-022). Experiments were conducted in accordance with the Public Health Service 
policy on ‘Humane Care and Use of Laboratory Animals’ and the Assessment and Accreditation of Laboratory 
Animal Care guidelines. Balb/c mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) and 
studied at eight weeks of age. Equal numbers of male and female were included in each group, with 6–10mice/
PBS control group and 8–12/HDM group. Mice were administered 50 ug of intranasal HDM (Greer Laboratories, 
Lenoir, NC, USA) in sterile PBS (1 mg protein/mL) or PBS alone on 7 occasions over three weeks: on days 0, 7 and 
14–18 (Fig. 1). Mice were evaluated 72 hours following the final instillation.
Mice were exposed for 30 min twice/day, 6 days/week consistent with total daily e-cigarette exposure times 
of previous studies34,39,40. Exposures started at Day 0 before the first administration of HDM/PBS and continued 
until Day 18 following the last administration of HDM/PBS. On days 0, 7 and 14–18, at least 60 min was left 
between e-cigarette exposure and HDM/PBS administration, and between HDM/PBS administration and the 
second daily e-cigarette exposure. For exposures, mice were placed in a Perspex box (W × L × H = 25.4 × 17.
8 × 20.3 cm) connected to a MasterFlex® peristaltic pump (Cole Palmer, Vernon Hills, IL, USA) set a 1 L/min. 
Room Air exposure involved continuously running the pump when disconnected from the e-cigarette device. For 
e-cigarette exposure, aerosols were produced using a variable temperature control eVic-VT e-cigarette (Joyetech 
USA, Tustin, CA, USA) using a titanium coil (0.4Ω) set at 550 °F with a limit of 45 W. The e-cigarette device 
was actuated for 4 s every 60 s to reflect human use57, with room air continuously pumped between actuations. 
Separate e-cigarette atomizers were used for each flavor and nicotine concentration. Separate exposure chambers 
were used for 0 mg/mL and 12 mg/mL nicotine exposures and chambers were thoroughly cleaned after each 
exposure.
Mice were exposed to room air or one of the following e-cigarette liquids; vehicle control (50% vegetable 
glycerin/%50 propylene glycol, PG/VG), Black Licorice, Kola, Banana Pudding and Cinnacide (Table 1). Liquids 
contained either 0 mg/ml or 12 mg/ml nicotine for each liquid.
Assessment of airway mechanics and airway hyperresponsiveness (AHR). Mice were anesthe-
tized with intraperitoneal pentobarbital sodium (90 mg/kg), tracheotomized, and mechanically ventilated at 
200 breaths/min with a tidal volume of 0.25 mL and positive end-expiratory pressure of 3 cmH2O (FlexiVent, 
SCIREQ, QC, Canada). Airway mechanics were assessed by the forced oscillation technique in which respiratory 
impedance was partitioned into respiratory system resistance and respiratory system elastance, a measure of the 
stiffness of the lung. Airway mechanics were also measured by input impedance in which the Constant Phase 
Model58 provides measurements of Newtonian resistance (Rn), a measure of airway resistance, tissue damping 
(G), a measure of tissue resistance and tissue elastance (H), a measure of lung stiffness. Airway responsiveness 
was assessed during airway challenge with increasing doses of aerosolized methacholine (saline control, 3.125, 
12.5, 25 and 50 mg/ml). The response to methacholine at each dose was quantified as the average of the three 
consecutive peak measurements.
Collection and analysis of bronchoalveolar lavage. Lungs were lavaged with 1.0 ml of PBS and centri-
fuged at 1200 × g for 5 minutes to isolate cells. Total cell counts were performed using the Countess Automated 
Cell Counter (Invitrogen, Waltham, MA). Differential cell counts were performed using the Hema3 kit (Fisher 
Scientific, Kalamazoo, MI) by counting 300 cells per mouse.
Measurement of collagen content. Newly deposited lung collagen was measured in the upper right lobe 
using the Sircol Assay (Biocolor, UK) after overnight digestion with 10 mg/ml pepsin in 0.5 M acetic acid as 
directed by the manufacturer.
Histopathology. Lungs were inflated to 30 cmH2O and fixed with 4% paraformaldehyde in PBS followed 
by paraffin embedding. Paraffin blocks were cut into 5 µm sections and mounted to slides. Inflammatory cell 
Commercial name Humectant Nicotine Company
Control 50% PG/50% VG 0 ml/mL Vapor Girl, Chapel Hill, NC, USA
Control 50% PG/50% VG 12 ml/mL Vapor Girl, Chapel Hill, NC, USA
Black Licorice 50% PG/50% VG 0 mg/mL Tasty Vapor, Oakland, CA, USA
Kola 55% PG/45% VG 0 mg/mL Vapor Girl, Chapel Hill, NC, USA
Banana Pudding 55% PG/45% VG 0 mg/mL Vapor Girl, Chapel Hill, NC, USA
Cinnacide 55% PG/45% VG 0 mg/mL The Vapor Depot, Ponderay, ID, USA
Black Licorice 50% PG/50% VG 12 mg/mL Tasty Vapor, Oakland, CA, USA
Banana Pudding 55% PG/45% VG 12 mg/mL Vapor Girl, Chapel Hill, NC, USA
Atomic Cinnacide* 55% PG/45% VG 12 mg/mL Dodgy Brothers, Malaysia
Table 1. Details of the e-cigarette liquids used for exposure. PG = propylene glycol, VG = vegetable glycerin 
*E-cigarette was produced by Tasty Vapor but purchased from a secondary source after Tasty Vapor 
discontinued production.
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infiltration in the lung was confirmed from hematoxylin and eosin stained sections. Mucus metaplasia was 
assessed from lung sections stained with periodic-acid Schiff reagent. Five bronchiolar airways (x40 magnifica-
tion) were imaged from each slide and the percentage of PAS staining within the epithelial layer was calculated 
using Metamorph image analysis software (Molecular Devices, Sunnyvale, CA).
Statistical analysis. The effects of e-cigarettes were evaluated by linear least squares regression using 
effect parameters for HDM challenge, e-cigarette exposure and an interaction between the two (JMP® Pro 10, 
SAS Institute Inc., Cary, NC, USA). Subsequent comparisons between HDM treated mice exposed to Room 
Air and e-cigarettes were performed using Dunnett post-hoc analyses. PAS staining data were analyzed by 
repeat-measures to account for multiple airways from each individual lung slice. Separate analyses were per-
formed for e-cigarettes exposures with (12 mg/mL) and without nicotine (0 mg/mL) but the same Room Air 
control data were used for both analyses. Data are presented as mean ± SEM or median ± IQR and p values < 0.05 
were regarded as statistically significant.
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